Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Glaxosmithkline plc crawled time : 13:30 save search
GSK Exercises Option to License Elsie Biotechnologies’ Discovery Platform to Find and Develop Novel Oligonucleotides
Published: 2024-02-14 (Crawled : 13:30) - biospace.com/
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.41%
C: 0.1%
license platform
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology
Published: 2024-01-24 (Crawled : 13:30) - biospace.com/
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.48%
H: 0.66%
C: -1.11%
collaboration dna technology agreement
Sports Nutrition Market in Europe - 40% of Growth to Originate from the UK| Non-Protein Sports Nutrition Segment to be Significant for Revenue Generation |17000+ Technavio Reports
Published: 2022-03-14 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 9.61%
H: 0.0%
C: -0.57%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -2.3%
H: 0.0%
C: 0.0%
europe nutrition origin report growth
Benign Prostatic Hyperplasia Therapeutics Market to Reach $9.39 Bn, Globally, by 2030 at 5.0% CAGR: Allied Market Research
Published: 2022-02-22 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -0.57%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 1.84%
H: 0.49%
C: 0.09%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: -0.61%
H: 1.05%
C: -0.86%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.93%
H: 0.77%
C: 0.12%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.21%
H: 2.39%
C: 0.83%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.26%
H: 0.81%
C: 0.46%
research therapeutics
Dermatologicals Market to Reach $59.30 Bn, Globally, by 2030 at 11.50% CAGR: AMR
Published: 2022-02-21 (Crawled : 13:30) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
als dermatological derm
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.67%
H: 3.62%
C: 3.62%
PPG A | $130.52 0.07% 0.0% 1.6M
|
Process Industries
|
| O: -2.07%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
PHAT | $9.12 0.66% 0.66% 440K
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
space spac
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.36%
H: 0.46%
C: 0.46%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: -4.59%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
covid-19 treatment europe granted covid authorization grant
GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting
Published: 2021-11-18 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -6.25%
H: 3.09%
C: -0.45%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -1.66%
H: 0.24%
C: -0.12%
trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.